MedGemma, a medical general-purpose foundation model derived from Gemini and its fine-tuned version adapted for lung cancer detection and diagnosis is compared against radiologists performing Lung-RADS v2022 assessment on the NLST dataset, supporting the role of fine-tuned foundation models potential complementary tools for clinical decision support.
Abstract
Foundation models have recently demonstrated strong capabilities across a wide range of medical imaging tasks. However, their performance in structured clinical interpretation settings remains insufficiently explored. In lung cancer screening, interpretative variability persists despite standardized frameworks such as Lung-RADS. In this study, we evaluate MedGemma, a medical general-purpose foundation model derived from Gemini and its fine-tuned version adapted for lung cancer detection and diagnosis, compared against radiologists performing Lung-RADS v2022 assessment on the NLST dataset. Twelve radiologists independently evaluated each case in a multi-reader design, enabling quantification of inter-reader variability. Radiologists achieved a mean AUC of 0.90, with substantial variability across readers (range: 0.80-0.94). The native foundation model achieved an AUC of 0.70, failing to reach clinically relevant performance. In contrast, fine-tuning significantly improved performance to an AUC of 0.83, placing the model within the lower range of individual radiologists performance. These findings highlight a trade-off between peak accuracy and prediction consistency. Unlike radiologists, under fixed conditions, the model produces deterministic outputs, removing inter-run variability under identical inputs, in contrast to inter-reader variability observed among radiologists. This supports the role of fine-tuned foundation models potential complementary tools for clinical decision support, particularly in settings with limited expertise. However, evaluation is performed on a case-enriched cohort from NLST and does not account for real-world prevalence or external validation, limiting direct clinical generalization.
This systematic review evaluated forty-two studies published between 2024 and 2026 across eleven databases using PRISMA 2020 guidelines and AI-specific quality frameworks and demonstrated high organ segmentation accuracy with Dice coefficients exceeding 0.90, whereas performance declined for infiltrative tumours, and e...
A reproducible, end-to-end methodology that jointly optimizes performance and interpretability, offering practical guidance for selecting and deploying explainable deep learning models in clinical pneumonia screening is contributed.
Francisco A. Gómez-Vela, Aurelio López-Fernández, F. Divina et al.· Applied intelligence (Boston...· 0 citations
Artificial-intelligence (AI) research on lung cancer in 2026 shows rapid growth across lightweight convolutional networks, CNN–transformer hybrids, capsule-inspired models, segmentation-driven pipelines, radiomics, multimodal fusion and reader-assistance systems. Model selection is now more than accuracy maximisation:...
A. Sirajdeen, S. Rajakumaran· Scholar Journal of Commerce...· 0 citations
Most existing artificial intelligence systems for breast ultrasound rely primarily on image-driven prediction, with limited incorporation of the knowledge from the Breast Imaging Reporting and Data System (BI-RADS) and the intermediate assessment processes underlying radiologists'workflow, thereby constraining their in...
Sheng-Zhou Zhong, Zi-Yi Wang, Lian-Fu Li et al.· 0 citations
The addition of clinical information was associated with a numeric trend toward higher diagnostic accuracy overall, but this trend was heterogeneous across models and disease types, and no statistically significant improvement was demonstrated after adjustment for multiple comparisons.
Jin-Qi Zhang, Xiao-Yi Wang, Yanfeng Zhao et al.· Journal of Medical Internet...· 0 citations
The near-perfect in-site AUC is therefore most plausibly explained by acquisition-related confounding, which extends beyond reconstruction protocol to scanner model and age, and is not evidence of malignancy discrimination.
Known for his clear and elegant writing style, Bertsekas shaped fields from control and optimization to large-scale computation and artificial intelligence.